Raymond James Maintains Outperform on DexCom, Raises Price Target to $618

Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $515 to $618.

Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $515 to $618.

Total
0
Shares
Related Posts